CONEXXENCE INJVLST 60MG/ML WWSP 1ML

Active substance
DENOSUMAB
Therapeutical formulation
INJECTIEVLOEISTOF

€ 182.89 excluding delivery costs.

This drug is fully reimbursed by your health insurance company.

Aan de vergoeding van dit geneesmiddel zijn voorwaarden verbonden.

Own risk

€ 182.89

This is the amount charged to your deductible .

Strength
60MG/ML
Supplier
FRESENIUS KABI NEDERLAND BV
Available outside pharmacies
No
Remarks
  • This medicine is available by prescription only.
EU number
EU/1/25/1954/01

Conditions

Insurer

Health insurers have the option for a number of drugs to reimburse only certain variants (e.g., based on their pricing or price agreements between health insurer and drug manufacturer). We call this preference policy. If your health insurer has a preference policy for one or more drugs, it is stated in your insurance policy. If there is a medical necessity to use a more expensive variant of the drug anyway, your health insurer may deviate from the preference policy. The way in which health insurers implement the preference policy varies from one health insurer to another. Therefore, for more information, consult your insurance policy or contact your health insurer.

Variants

Alternatives

See also